(RTTNews) - Providing certain unaudited preliminary third quarter results on Friday, medical technology company Integra LifeSciences Holdings Corp. (IART) trimmed its adjusted earnings and revenue guidance for the full-year 2026, based on revised assumptions regarding the expecte
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.